b12 Labs
Making hard molecules for Pharma and Biotech
San Francisco
3 employees
Drug Discovery and Delivery
Seed · $500K
About b12 Labs
Making hard molecules for Pharma and Biotech
Making hard molecules for Pharma and Biotech
Making hard molecules for Pharma and Biotech
Total raised
$500K
Last stage
Seed
Investors
Zlatko Jončev
at b-12 we are developing AI agents for automated workflows in chemistry and pharma R&D, as a way of manifestating chemical super intelligence in physical world. our long-term goal is to create autonomous labs that can perform complex, multistep syntheses with minimal human intervention.
LinkedIn
Andres Bran
Before b-12, Andres built the first AI agent to plan and make molecules in a robotic lab (750+ cites in Nature Machine Intelligence, and Best Paper at NeurIPS AI for Science), along with several other works in agents and LLMs for chemistry (1100+ citations). He was an Intern at Max Planck (Math in Science), and PhD at EPFL (AI+Chemistry). Automation is the future of chemistry, but integration and human operability is the hidden demon nobody talks about. We're fixing that at b-12.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.